UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 346

Sortiert nach

Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

Anti-cancer agents in medicinal chemistry, 2012-02, Vol.12 (2), p.163

Yokota, Tomoya

2012

Volltextzugriff (PDF)

Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer

Case reports in oncology, 2022-09, Vol.15 (3), p.833-840

Yokota, Tomoya

2022

Volltextzugriff (PDF)

Asymmetric Friedel–Crafts-Type Reaction of 2‑Vinylindoles to N‑Boc Imines Using a Chiral Imidazolidine-Containing NCN-Pincer Pd Catalyst

Journal of organic chemistry, 2023-06, Vol.88 (12), p.7872-7881

2023

Volltextzugriff (PDF)

ASO Author Reflections: How Should the Patients with Locally Advanced Unresectable Esophageal Cancer Be Treated with Multidisciplinary Approach?

Annals of surgical oncology, 2020-02, Vol.27 (2), p.468-469

2020

Volltextzugriff (PDF)

Is biomarker research advancing in the era of personalized medicine for head and neck cancer?

International journal of clinical oncology, 2014-04, Vol.19 (2), p.211-219

Yokota, Tomoya

2014

Volltextzugriff (PDF)

Immunotherapy for squamous cell carcinoma of the head and neck

Japanese journal of clinical oncology, 2020-10, Vol.50 (10), p.1089-1096

2020

Volltextzugriff (PDF)

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma

Case reports in oncology, 2020-05, Vol.13 (2), p.522-527

2020

Volltextzugriff (PDF)

Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck

International journal of clinical oncology, 2021-10, Vol.26 (10), p.1822-1830

2021

Volltextzugriff (PDF)

Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study

International journal of clinical oncology, 2021-03, Vol.26 (3), p.494-506

2021

Volltextzugriff (PDF)

Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma

International journal of clinical oncology, 2020-05, Vol.25 (5), p.972-977

2020

Volltextzugriff (PDF)

PSY7-4 Novel de-escalation strategy for HPV-positive oropharyngeal cancer

Annals of oncology, 2022-07, Vol.33, p.S422

Yokota, Tomoya

2022

Volltextzugriff (PDF)

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

BMC cancer, 2023-01, Vol.23 (1), p.68-8, Article 68

2023

Volltextzugriff (PDF)

Multidisciplinary tumor board for head and neck cancer from the perspective of medical oncologists—optimizing its effectiveness

Frontiers in oncology, 2023-08, Vol.13, p.1257853-1257853

2023

Volltextzugriff (PDF)

Pre-treatment tumor size impacts on response to nivolumab in head and neck squamous cell carcinoma

Auris, nasus, larynx, 2020-08, Vol.47 (4), p.650-657

2020

Volltextzugriff (PDF)

A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer

Annals of surgical oncology, 2020-02, Vol.27 (2), p.460-467

2020

Volltextzugriff (PDF)

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil

International journal of clinical oncology, 2020-11, Vol.25 (11), p.1914-1920

2020

Volltextzugriff (PDF)

Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer

BMC cancer, 2022-10, Vol.22 (1), p.1-1101, Article 1101

2022

Volltextzugriff (PDF)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck

Japanese journal of clinical oncology, 2021-02, Vol.51 (2), p.173-179

2021

Volltextzugriff (PDF)

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)

Japanese journal of clinical oncology, 2019-07, Vol.49 (7), p.589-595

2019

Volltextzugriff (PDF)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer

BMC cancer, 2020-03, Vol.20 (1), p.182-182, Article 182

2020

Volltextzugriff (PDF)

First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048

International journal of clinical oncology, 2022-12, Vol.27 (12), p.1805-1817

2022

Volltextzugriff (PDF)

Sesamin, a lignan of sesame, down‐regulates cyclin D1 protein expression in human tumor cells

Cancer science, 2007-09, Vol.98 (9), p.1447-1453

2007

Volltextzugriff (PDF)

Human papillomavirus-related oropharyngeal carcinoma

Japanese journal of clinical oncology, 2022-07, Vol.52 (7), p.700-706

2022

Volltextzugriff (PDF)

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study

BMC cancer, 2018-05, Vol.18 (1), p.573-573, Article 573

2018

Volltextzugriff (PDF)

Chemoradiotherapy for high-risk stage II laryngeal cancer

International journal of clinical oncology, 2020-09, Vol.25 (9), p.1596-1603

2020

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(325)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(187)
Humans
(121)
Oncology
(120)
Female
(75)
Male
(75)
Aged
(66)
Chemotherapy
(66)
Middle Aged
(64)
Medicine
(61)
Medicine & Public Health
(59)
Retrospective Studies
(45)
Original Article
(39)
Cancer Research
(37)
Patients
(37)
Adult
(36)
Surgical Oncology
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Treatment Outcome
(31)
Aged, 80 And Over
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer

Asymmetric Friedel–Crafts-Type Reaction of 2‑Vinylindoles to N‑Boc Imines Using a Chiral Imidazolidine-Containing NCN-Pincer Pd Catalyst

ASO Author Reflections: How Should the Patients with Locally Advanced Unresectable Esophageal Cancer Be Treated with Multidisciplinary Approach?

Is biomarker research advancing in the era of personalized medicine for head and neck cancer?

Immunotherapy for squamous cell carcinoma of the head and neck

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma

Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck

Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study

Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma

PSY7-4 Novel de-escalation strategy for HPV-positive oropharyngeal cancer

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

Multidisciplinary tumor board for head and neck cancer from the perspective of medical oncologists—optimizing its effectiveness

Pre-treatment tumor size impacts on response to nivolumab in head and neck squamous cell carcinoma

A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil

Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer

First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048

Sesamin, a lignan of sesame, down‐regulates cyclin D1 protein expression in human tumor cells

Human papillomavirus-related oropharyngeal carcinoma

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study

Chemoradiotherapy for high-risk stage II laryngeal cancer

Suchergebnisse filtern